New 52 Week Low Today

Aridis Pharmaceuticals Inc ARDS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:22 PM EDT
4.76quote price arrow down-0.32 (-6.30%)
Volume
247,293
52 week range
4.55 - 8.50

...

Loading . . .
  • Open5.11
  • Day High5.11
  • Day Low4.55
  • Prev Close5.08
  • 52 Week High8.50
  • 52 Week High Date10/22/20
  • 52 Week Low4.55
  • 52 Week Low Date07/27/21

Key Stats

  • Market Cap53.46M
  • Shares Out11.23M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • YTD % Change-21.61

KEY STATS

  • Open5.11
  • Day High5.11
  • Day Low4.55
  • Prev Close5.08
  • 52 Week High8.50
  • 52 Week High Date10/22/20
  • 52 Week Low4.55
  • 52 Week Low Date07/27/21
  • Market Cap53.46M
  • Shares Out11.23M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • YTD % Change-21.61

RATIOS/PROFITABILITY

  • EPS (TTM)-2.48
  • P/E (TTM)-1.92
  • Fwd P/E (NTM)-2.56
  • EBITDA (MRQ)-22.399M
  • ROE (MRQ)-1,000.79%
  • Revenue (MRQ)1.00M
  • Gross Margin (MRQ)11.68%
  • Net Margin (MRQ)-2,272.00%
  • Debt To Equity (MRQ)-8.36%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aridis Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Aridis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs), to treat infections. mAbs represents treatment approach that enables the human immune system to fight infections and are designed to overcome the deficiencies associated with current therapies, such as rise in drug resistance, short duration of response, negative impact on the human microbiome, and lack...
Address
983 UNIVERSITY AVENUE, BLDG. B
Los Gatos, CA
95032
United States

Top Peers

SYMBOLLASTCHG%CHG
OTLC
Oncotelic Therapeutics Inc
0.175UNCHUNCH
TCON
TRACON Pharmaceuticals Inc
3.72-0.09-2.36%
VCNX
Vaccinex Inc
2.34UNCHUNCH
BCDA
BioCardia Inc
3.39+0.03+0.89%
DFFN
Diffusion Pharmaceuticals Inc
0.5215-0.0229-4.2065%